


Healthcare Industry NewsFeed
HSMN NewsFeed - 13 Jul 2016
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
HSMN NewsFeed - 12 Jul 2016
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
HSMN NewsFeed - 12 Jul 2016
Federal Circuit Rules for The Medicines Company in Angiomax(R) (bivalirudin) Patent Litigation
Federal Circuit Rules for The Medicines Company in Angiomax(R) (bivalirudin) Patent Litigation
HSMN NewsFeed - 12 Jul 2016
Alere to Initiate Voluntary Withdrawal of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitoring System
Alere to Initiate Voluntary Withdrawal of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitoring System
HSMN NewsFeed - 11 Jul 2016
IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development
IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development
HSMN NewsFeed - 8 Jul 2016
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
HSMN NewsFeed - 8 Jul 2016
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
HSMN NewsFeed - 6 Jul 2016
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
HSMN NewsFeed - 6 Jul 2016
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
HSMN NewsFeed - 1 Jul 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
HSMN NewsFeed - 1 Jul 2016
InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million
InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million
HSMN NewsFeed - 30 Jun 2016
Medline and Medic Management Group Launch New GPO Distribution Partnership
Medline and Medic Management Group Launch New GPO Distribution Partnership
